Science Explorer Back to mapMap
Discussion
Researcher · Jiangmen Central Hospital · China

Zhuming Lu

Zhuming Lu publishes mostly in Pulmonary and Respiratory Medicine, Molecular Biology and Oncology, on topics such as Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations and Cancer Immunotherapy and Biomarkers.

OpenAlex
World rank
#1,248,864
of 7,710,434 ranked researchers
Rank in China
#181,838
of 978,568
Works
27
Citations
616
Citations per work
22.8
h-index
12
i10-index 12Top 42% in Pulmonary and Respiratory Medicine
Zhuming Lu

What does Zhuming Lu research?

Zhuming Lu's work is mostly in Medicine (46%), Biochemistry, Genetics and Molecular Biology (27%).

Health Sciences: 13 works · 46.5% of their workMedicine: 13 works · 46.5% of their workPulmonary and Respiratory Medicine: 7 works · 27.4% of their workOncology: 3 works · 12.3% of their workSurgery: 2 works · 6.8% of their workLife Sciences: 7 works · 27.4% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 27.4% of their workMolecular Biology: 4 works · 13.7% of their workCancer Research: 3 works · 9.6% of their workGenetics: 1 works · 4.1% of their workEverything else: 7 works · 26.1% of their workTHEIR WORKZhuming Lu27works
Life Sciences27%Health Sciences46%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1346.5%
    1. Biochemistry, Genetics and Molecular Biology727.4%
  3. Everything else726.1%
  1. 1Pulmonary and Respiratory Medicine27% of their works
  2. 2Molecular Biology14% of their works
  3. 3Oncology12% of their works
  4. 4Cancer Research10% of their works
  5. 5Surgery7% of their works
  6. 6Genetics4% of their works

Research topics

Which keywords describe Zhuming Lu's research?

The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, CT Screening, Lung Cancer, Tumor Microenvironment, ALK Inhibitors and EGFR Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 24 words, with their numbers
  1. Chemotherapy102 topics
  2. Clinical Trials92 topics
  3. Targeted Therapy92 topics
  4. CT Screening71 topic
  5. Lung Cancer71 topic
  6. Tumor Microenvironment72 topics
  7. ALK Inhibitors61 topic
  8. EGFR Mutations61 topic
  9. Biomarkers52 topics
  10. Cancer52 topics
  11. Gene Expression52 topics
  12. Metastasis52 topics
  13. Immune Checkpoint Blockade41 topic
  14. PD-1 and PD-L141 topic
  15. Cell Death31 topic
  16. Estrogen31 topic
  17. Ferroptosis31 topic
  18. Genomic Profiles31 topic
  19. Pulmonary Alveolar Microlithiasis31 topic
  20. Pulmonary Sclerosing Hemangioma31 topic
  21. Receptor31 topic
  22. Small-Cell Lung Cancer31 topic
  23. MicroRNA21 topic
  24. Regulation21 topic

Where does Zhuming Lu work?

Zhuming Lu's main affiliation in the publication record is Jiangmen Central Hospital, China.

How many publications and citations does Zhuming Lu have?

OpenAlex counts 27 works and 616 citations for Zhuming Lu, an h-index of 12, ranking #1,248,864 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Zhuming Lu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.